197 related articles for article (PubMed ID: 15136495)
1. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy.
Terracciano CM; Hardy J; Birks EJ; Khaghani A; Banner NR; Yacoub MH
Circulation; 2004 May; 109(19):2263-5. PubMed ID: 15136495
[TBL] [Abstract][Full Text] [Related]
2. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
3. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
[TBL] [Abstract][Full Text] [Related]
4. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy.
Terracciano CM; Harding SE; Adamson D; Koban M; Tansley P; Birks EJ; Barton PJ; Yacoub MH
Eur Heart J; 2003 Jul; 24(14):1329-39. PubMed ID: 12871690
[TBL] [Abstract][Full Text] [Related]
5. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inhibition alters subcellular calcium release patterns in rat ventricular myocytes: implications for defective excitation-contraction coupling during cardiac ischemia and failure.
Fukumoto GH; Lamp ST; Motter C; Bridge JH; Garfinkel A; Goldhaber JI
Circ Res; 2005 Mar; 96(5):551-7. PubMed ID: 15718501
[TBL] [Abstract][Full Text] [Related]
7. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
[TBL] [Abstract][Full Text] [Related]
8. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
[TBL] [Abstract][Full Text] [Related]
9. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
[TBL] [Abstract][Full Text] [Related]
10. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
[TBL] [Abstract][Full Text] [Related]
11. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
12. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
13. Cardiac recovery during mechanical assist device support.
Maybaum S; Kamalakannan G; Murthy S
Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
[TBL] [Abstract][Full Text] [Related]
14. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
16. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
[TBL] [Abstract][Full Text] [Related]
17. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
19. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
